(S (NP (NP (DT Both) (JJ radiographic) (NML (-LRB- -LRB-) (NN Rad) (-RRB- -RRB-) (NN imaging))) (, ,) (PP (JJ such) (IN as) (NP (NP (JJ multi-parametric) (NML (NML (JJ magnetic) (NN resonance) (NN imaging)) (, ,) (CC and) (NML (JJ digital) (NN pathology) (PRN (-LRB- -LRB-) (NP (NN Path)) (-RRB- -RRB-)))) (NNS images)) (VP (VBN captured) (PP (IN from) (NP (NN tissue) (NNS samples))))))) (VP (VBP are) (ADVP (RB currently)) (VP (VBN acquired) (PP (IN as) (NP (NP (JJ standard) (JJ clinical) (NN practice)) (PP (IN for) (NP (NN glioblastoma) (NNS tumors))))))) (. .))
(S (NP (PDT Both) (DT these) (NNS data) (NNS streams)) (VP (VBP have) (VP (VBN been) (ADVP (RB separately)) (VP (VBN used) (PP (IN for) (NP (NML (NN diagnosis) (CC and) (NN treatment)) (NN planning))) (, ,) (PP (IN despite) (NP (NP (DT the) (NN fact)) (SBAR (IN that) (S (NP (PRP they)) (VP (VBP provide) (NP (JJ complementary) (NN information)))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN research) (NN work))) (, ,) (NP (PRP we)) (VP (VBD aimed) (S (VP (TO to) (VP (VB assess) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (DT both) (NML (NN Rad) (CC and) (NN Path)) (NNS images)))) (PP (IN in) (NP (NN combination) (CC and) (NN comparison))))))) (. .))
(S (NP (NP (DT An) (JJ extensive) (NN set)) (PP (IN of) (NP (VBN engineered) (NNS features)))) (VP (VBD was) (VP (VBN extracted) (PP (IN from) (NP (NP (VBN delineated) (NN tumor) (NNS regions)) (PP (IN in) (NP (NN Rad) (NNS images))))) (, ,) (S (VP (VBG comprising) (NP (NP (NN T1)) (, ,) (NP (NN T1) (HYPH -) (NN Gd)) (, ,) (NP (NN T2)) (, ,) (NP (NN T2) (HYPH -) (NN FLAIR)) (, ,) (CC and) (NP (NP (CD 100) (JJ random) (NNS patches)) (VP (VBN extracted) (PP (IN from) (NP (NN Path) (NNS images)))))))))) (. .))
(S (ADVP (RB Specifically)) (, ,) (NP (NP (DT the) (NNS features)) (VP (VBN comprised) (NP (NP (NNS descriptors)) (PP (IN of) (NP (NN intensity) (, ,) (NN histogram) (, ,) (CC and) (NN texture)))))) (, ,) (ADVP (RB mainly)) (VP (VBD quantified) (PP (IN via) (NP (NML (NML (NML (JJ gray) (HYPH -) (NN level)) (HYPH -) (NML (NN co-occurrence) (NN matrix))) (CC and) (NML (NML (JJ gray) (HYPH -) (NN level)) (HYPH -) (NML (NN run) (HYPH -) (NN length)))) (NNS matrices)))) (. .))
(S (NP (NP (NP (NNS Features)) (VP (VBN extracted) (PP (IN from) (NP (NP (NNS images)) (PP (IN of) (NP (CD 107) (NN glioblastoma) (NNS patients))))))) (, ,) (VP (VBN downloaded) (PP (IN from) (NP (DT The) (NNP Cancer) (NNP Imaging) (NNP Archive)))) (, ,)) (VP (VBD were) (VP (VBN run) (PP (IN through) (NP (NP (NN support) (NN vector) (NN machine)) (PP (IN for) (NP (NN classification))))) (S (VP (VBG using) (NP (NML (NML (NN leave) (HYPH -) (CD one)) (HYPH -) (PP (IN out) (NP (JJ cross-validation) (NN mechanism)))) (, ,) (CC and) (PP (IN through) (NP (NP (NN support) (NN vector) (NN regression)) (PP (IN for) (NP (NN prediction))))) (PP (IN of) (NP (JJ continuous) (NN survival))) (NN outcome)))))) (. .))
(S (NP (DT The) (NNP Pearson) (NN correlation) (NN coefficient)) (VP (VBD was) (VP (VBN estimated) (S (VP (TO to) (VP (VB be) (NP (NP (CD 0.75) (, ,) (CD 0.74) (, ,) (CC and) (CD 0.78)) (PP (IN for) (NP (NML (NML (NN Rad)) (, ,) (NML (NN Path)) (CC and) (NML (NNP RadPath))) (NNS data))))))))) (. .))
(S (NP (NP (NP (DT The) (NN area)) (HYPH -) (PP (IN under) (NP (DT the) (NN receiver)))) (VP (VBG operating) (NP (JJ characteristic) (NN curve)))) (VP (VBD was) (VP (VBN estimated) (S (VP (TO to) (VP (VB be) (NP (NP (CD 0.74) (, ,) (CD 0.76) (CC and) (CD 0.80)) (PP (IN for) (NP (NML (NML (NN Rad)) (, ,) (NML (NN Path)) (CC and) (NML (NNP RadPath))) (NNS data)))) (, ,) (SBAR (WHADVP (WRB when)) (S (NP (NNS patients)) (VP (VBD were) (VP (VBN discretized) (PP (IN into) (NP (NML (ADJP (JJ long) (HYPH -) (CC and) (JJ short)) (HYPH -) (NN survival)) (NNS groups))) (PP (VBN based) (PP (IN on) (NP (JJ average) (NN survival) (NN cutoff))))))))))))) (. .))
(S (NP (PRP$ Our) (NNS results)) (VP (VBP support) (NP (DT the) (NN notion)) (SBAR (IN that) (S (S (ADVP (RB synergistically)) (VP (VBG using) (NP (NML (NN Rad) (CC and) (NN Path)) (NNS images)))) (VP (MD may) (VP (VB lead) (PP (IN to) (NP (NP (JJR better) (NN prognosis)) (PP (IN at) (NP (NP (DT the) (JJ initial) (NN presentation)) (PP (IN of) (NP (DT the) (NN disease))))))))))) (, ,) (S (ADVP (RB thereby)) (VP (VBG facilitating) (NP (NP (DT the) (VBN targeted) (NN enrollment)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN into) (NP (JJ clinical) (NNS trials))))))))) (. .))
